FOXP3 and breast carcinoma: As downstream targets of FOXP3, miR-200c and miR-141 were downregulated in the breast cancer tissue of animal models and TCGA human breast cancer tissue samples but upregulated in plasma samples of both humans and mice with metastatic disease.